Trevi Therapeutics, Inc. (TRVI) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 176.12M | 191.66M | 198.3M | 207.23M | 105.62M | 109.43M | 67.34M | 72.13M | 76.77M | 87.55M | 93.95M | 99.21M | 114.2M | 122.62M | 127.32M | 79.89M | 29.84M | 37.96M | 30.71M | 38.48M |
| Cash & Short-Term Investments | 171.78M | 188.26M | 194.93M | 203.88M | 103.26M | 107.62M | 65.49M | 69.5M | 72.82M | 82.97M | 88.87M | 94.15M | 111.26M | 120.51M | 125.6M | 77.86M | 29.11M | 36.83M | 29.32M | 36.42M |
| Cash Only | 19.41M | 18.91M | 56.87M | 117.06M | 19.37M | 34.1M | 16.05M | 12.96M | 13.81M | 32.4M | 25.96M | 13.75M | 11.65M | 12.59M | 66.57M | 24.7M | 29.11M | 36.83M | 29.32M | 36.42M |
| Short-Term Investments | 152.37M | 169.35M | 138.06M | 86.83M | 83.88M | 73.53M | 49.44M | 56.53M | 59.01M | 50.57M | 62.9M | 80.4M | 99.61M | 107.92M | 59.03M | 53.16M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 986K | 0 | 0 | 0 | 532K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 241K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.34M | 2.41M | 2M | 1.58M | 834K | 335K | 667K | 830K | 721K | 955K | 1.05M | 2.08M | 1.61M | 1.31M | 421K | 382K | 249K | 0 | 0 | 0 |
| Total Non-Current Assets | 3.48M | 1.78M | 1.06M | 1.11M | 1.38M | 1.47M | 1.57M | 1.68M | 1.79M | 1.86M | 1.94M | 1.76M | 2M | 399K | 1.04M | 1.53M | 547K | 518K | 889K | 669K |
| Property, Plant & Equipment | 875K | 855K | 954K | 1.04M | 1.14M | 1.23M | 1.32M | 1.41M | 1.48M | 1.56M | 1.65M | 1.7M | 1.78M | 194K | 121K | 116K | 149K | 184K | 222K | 259K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.61M | 928K | 103K | 68K | 241K | 243K | 256K | 273K | 311K | 297K | 297K | 68K | 225K | 205K | 922K | 413K | 398K | 334K | 667K | 410K |
| Total Assets | 179.61M | 193.44M | 199.36M | 208.34M | 107M | 110.9M | 68.91M | 73.81M | 78.56M | 89.4M | 95.9M | 100.98M | 116.2M | 123.02M | 128.36M | 81.41M | 30.39M | 38.48M | 31.6M | 39.15M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 67.85% | 74.43% | 189.31% | 182.26% | 36.21% | 24.05% | -28.14% | -26.9% | -32.4% | -27.32% | -25.29% | 24.03% | 282.43% | 219.73% | 306.26% | 107.96% | -29.11% | -18.37% | -43.46% | -16.72% |
| Total Current Liabilities | 7.12M | 9.75M | 9.04M | 9.24M | 6.87M | 10.51M | 9.12M | 6.75M | 5.28M | 5.82M | 5.17M | 4.71M | 13.2M | 13.4M | 14.64M | 15.43M | 12.87M | 12.72M | 9.91M | 9.41M |
| Accounts Payable | 2.21M | 3.91M | 2.71M | 2.97M | 1.42M | 3.41M | 1.61M | 1.51M | 2.11M | 1.81M | 1.26M | 1.35M | 1.98M | 2.86M | 2.33M | 3.94M | 1.74M | 2.85M | 2.23M | 3.49M |
| Days Payables Outstanding | 8.11K | - | - | - | - | 6.09K | - | 4.34K | 5.1K | 4.03K | - | - | - | - | - | - | - | 19.48K | - | - |
| Short-Term Debt | 318K | 307K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.48M | 7M | 7M | 7M | 7M | 5.83M | 4.08M | 2.33M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.58M | 5.53M | 2.39M | 1.87M | 1.07M | 2.54M | 0 | 3.43M | 906K | 1.61M | 1.22M | 1.09M | 618K | 0 | 0 | 0 | 125K | 114K | 1.13M | 1.2M |
| Current Ratio | 24.75x | 19.66x | 21.93x | 22.42x | 15.38x | 10.41x | 7.38x | 10.68x | 14.55x | 15.03x | 18.16x | 21.06x | 8.65x | 9.15x | 8.70x | 5.18x | 2.32x | 2.98x | 3.10x | 4.09x |
| Quick Ratio | 24.75x | 19.66x | 21.93x | 22.42x | 15.38x | 10.41x | 7.38x | 10.68x | 14.55x | 15.03x | 18.16x | 21.06x | 8.65x | 9.15x | 8.70x | 5.18x | 2.32x | 2.98x | 3.10x | 4.09x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 364K | 446K | 527K | 605K | 681K | 747K | 816K | 884K | 949K | 1.03M | 1.11M | 1.19M | 1.27M | 2.16M | 3.82M | 5.47M | 7.06M | 8.68M | 10.3M | 12M |
| Long-Term Debt | 364K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.15M | 3.8M | 5.43M | 7.06M | 8.65M | 10.24M | 11.91M |
| Capital Lease Obligations | 0 | 446K | 527K | 605K | 681K | 747K | 816K | 884K | 949K | 1.03M | 1.11M | 1.19M | 1.27M | 2K | 2K | 3K | 0 | 24K | 58K | 91K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 15K | 35K | 0 | 0 | 0 | 0 |
| Total Liabilities | 7.48M | 10.2M | 9.57M | 9.85M | 7.55M | 11.26M | 9.94M | 7.64M | 6.22M | 6.86M | 6.29M | 5.9M | 14.47M | 15.56M | 18.46M | 20.9M | 19.92M | 21.4M | 20.22M | 21.41M |
| Total Debt | 682K | 753K | 823K | 891K | 957K | 1.03M | 1.11M | 1.19M | 1.27M | 1.34M | 1.41M | 1.47M | 9.02M | 9.18M | 10.86M | 12.52M | 14.18M | 14.63M | 14.5M | 14.45M |
| Net Debt | -18.73M | -18.16M | -56.05M | -116.17M | -18.42M | -33.06M | -14.94M | -11.77M | -12.54M | -31.06M | -24.56M | -12.28M | -2.63M | -3.41M | -55.71M | -12.18M | -14.93M | -22.2M | -14.82M | -21.98M |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.09x | 0.09x | 0.10x | 0.21x | 1.36x | 0.86x | 1.27x | 0.81x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | -11398.00x | -13272.00x | -12359.00x | -10909.00x | -1949.75x | -2569.33x | -46.50x | -26.74x | -19.16x | -27.33x | -26.31x | -23.28x | -26.59x | -22.94x | -32.09x |
| Total Equity | 172.13M | 183.24M | 189.79M | 198.49M | 99.46M | 99.64M | 58.97M | 66.17M | 72.33M | 82.55M | 89.61M | 95.07M | 101.73M | 107.46M | 109.9M | 60.52M | 10.46M | 17.07M | 11.38M | 17.74M |
| Equity Growth % | 73.07% | 83.9% | 221.84% | 199.96% | 37.5% | 20.71% | -34.19% | -30.4% | -28.9% | -23.18% | -18.46% | 57.11% | 872.3% | 529.34% | 865.76% | 241.2% | -55.82% | -37.41% | -68.05% | -55.7% |
| Book Value per Share | 1.18 | 1.26 | 1.31 | 1.52 | 0.85 | 0.94 | 0.58 | 0.65 | 0.73 | 0.83 | 0.90 | 0.96 | 1.03 | 1.10 | 1.60 | 1.02 | 0.34 | 0.79 | 0.53 | 0.88 |
| Total Shareholders' Equity | 172.13M | 183.24M | 189.79M | 198.49M | 99.46M | 99.64M | 58.97M | 66.17M | 72.33M | 82.55M | 89.61M | 95.07M | 101.73M | 107.46M | 109.9M | 60.52M | 10.46M | 17.07M | 11.38M | 17.74M |
| Common Stock | 128K | 128K | 128K | 122K | 100K | 94K | 75K | 73K | 69K | 68K | 64K | 63K | 60K | 60K | 58K | 40K | 31K | 29K | 22K | 21K |
| Retained Earnings | -343M | -329.8M | -321.49M | -309.69M | -297.38M | -287.05M | -275.63M | -262.39M | -250.04M | -239.13M | -231.31M | -223.62M | -216.47M | -210.07M | -204.56M | -196.3M | -188.25M | -180.92M | -172.4M | -165.14M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -190K | 148K | 30K | 24K | 73K | 61K | 139K | -84K | -67K | -29K | -217K | -248K | -88K | -122K | -263K | -135K | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |